References
- Henningfield J. E. Nicotine medications for smoking cessation. N Engl J Med 1995; 333: 1196–1203
- Gorsline J., Gupta S. K., Dye D., Rolf C. N. Nicotine dose relationships for Nicoderm (nicotine transdermal system) at steady state. Pharm Res 1991; 10: S299
- Abelin T., Buehler A., Muller P., Vesanen K., Imhof P. R. Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet 1989; 1: 7–10
- Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. Six‐month results from two multicenter controlled clinical trials. JAMA 1991; 266: 3133–3138
- Fiore M. C., Jorenby D. E., Baker T. B., Kenford S. L. Tobacco dependence and the nicotine patch. Clinical guidelines for effective use. JAMA 1992; 268: 2687–2694
- Fiore M. C., Smith S. S., Jorenby D. E., Baker T. B. The effectiveness of the nicotine patch for smoking cessation. A meta‐analysis. JAMA 1994; 271: 1940–1947
- Orleans C. T., Resch N., Noll E., Keintz M. K., Rimer B. K., Brown T. V., Snedden T. M. Use of transdermal nicotine in a state‐level prescription plan for the elderly. JAMA 1994; 271: 601–607
- Kenford S. L., Fiore M. C., Jorenby D. E., Smith S. S., Wetter D., Baker T. B. Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA 1994; 271: 589–594
- Gourlay S. The pros and cons of transdermal nicotine therapy. Med J Aust 1994; 160: 152–159
- Hughes J. R. Risk‐benefit assessment of nicotine preparations in smoking cessation. Drug Saf 1993; 8: 49–56
- Anonymous. Nicotine patches. Med Lett Drug Ther 1992; 34: 37–38
- Fazier C. A. Side effects of nicotine patches. JAMA 1993; 270: 2735
- Fiore M., Hartman M. J. Side effects of nicotine patches. JAMA 1993; 270: 2735
- Dwyer C. M., Forsyth A. Allergic contact dermatitis from methacrylates in a nicotine transdermal patch. Contact Dermatitis 1994; 30: 309–310
- Vincenzi C., Tosti A., Cirone M., Guarrera M., Cusano F. Allergic contact dermatitis from transdermal nicotine systems. Contact Dermatitis 1993; 29: 104–105
- Farm G. Contact allergy to nicotine from a nicotine patch. Contact Dermatitis 1993; 29: 214–215
- Warner J. G., Jr, Little W. C. Myocardial infarction in a patient who smoked while wearing a nicotine patch. Ann Intern Med 1994; 120: 695
- Dacosta A., Guy J. M., Tardy B., et al. Myocardial infarction and nicotine patch: a contributing or causative factor?. Eur Heart J 1993; 14: 1709–1711
- Engel C. J., Parmentier A. H. Suicide attempts and the nicotine patch. JAMA 1993; 270: 323–324
- SmithKline Beecham Clinical Laboratories. Reference range for blood nicotine/cotinine concentrations for smokers (8–70 cigarettes/day). Van Nuys, California
- Saxena K., Scheman A. Suicide plan by nicotine poisoning: a review of nicotine toxicity. Vet Hum Toxicol 1985; 27: 495–497
- Lavoie F. W., Harris T. M. Fatal nicotine ingestion. J Emerg Med 1991; 9: 133–136
- Benowitz N. L., Jacob P J. U., Olsson P., Johansson C. J. Intravenous nicotine retards transdermal absorption of nicotine: evidence of blood flow‐limited percutaneous absorption. Clin Pharmacol Ther 1992; 52: 223–230